Screener
Medtronic MDT Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | January 23, 2026 | April 25, 2025 |
|---|---|---|
| Investments with readily determinable fair value (marketable equity securities) | $144 | $17 |
| Investments for which the fair value option has been elected | 50 | 140 |
| Investments without readily determinable fair values | 730 | 705 |
| Equity method and other investments | 79 | 89 |
| Total equity and other investments | $1,003 | $951 |
Item 1. Financial Statements
FAQ
- What is Medtronic's equity method investments?
- Medtronic (MDT) reported equity method investments of $730M in Q4 2025.
- How has Medtronic's equity method investments changed year-over-year?
- Medtronic's equity method investments decreased by 9.8% year-over-year, from $809M to $730M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Medtronic's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude